MoneyWorks4Me

Natural Capsules - Quaterly Results

09 May 2022 Evaluate
The Top line for the quarter ended March 2022 of Rs. 415.50 millions up 79.71% from Rs. 231.20 millions.Net Profit for the quarter ended March 2022 zoomed to 205.39% from Rs. 16.70 millions to Rs. 51.00  millions.Operating profit surged to 89.20 millions from the corresponding previous quarter of 37.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 415.50 231.20 79.71 1350.70 795.10 69.88 1350.70 795.10 69.88
Other Income 7.30 2.00 265.00 9.30 7.30 27.40 9.30 7.30 27.40
PBIDT 89.20 37.50 137.87 264.30 116.90 126.09 264.30 116.90 126.09
Interest 6.70 1.60 318.75 19.60 3.70 429.73 19.60 3.70 429.73
PBDT 82.50 35.90 129.81 244.70 135.00 81.26 244.70 135.00 81.26
Depreciation 13.90 11.30 23.01 50.40 43.10 16.94 50.40 43.10 16.94
PBT 68.60 24.60 178.86 194.30 91.90 111.43 194.30 91.90 111.43
TAX 17.60 7.90 122.78 54.70 22.40 144.20 54.70 22.40 144.20
Deferred Tax 2.70 2.60 3.85 7.30 0.20 3550.00 7.30 0.20 3550.00
PAT 51.00 16.70 205.39 139.60 69.50 100.86 139.60 69.50 100.86
Equity 70.10 62.30 12.52 70.10 62.30 12.52 70.10 62.30 12.52
PBIDTM(%) 21.47 16.22 32.36 19.57 14.70 33.09 19.57 14.70 33.09
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..